US 7435801
Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma
granted A61KA61K2039/505A61P
Quick answer
US patent 7435801 (Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61P, A61P37/00